Immune checkpoint inhibitor-mediated colitis is associated with cancer overall survival

doi:10.3748/wjg.v28.i39.5750

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 28, Issue 39

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (4692)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-1) series, Tables (1-4) series.

Item

Count

PDF

216

WORD

HTML

2263

Figures (1-1)

227

Tables (1-4)

242

Sum=2992

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

236

Download

517

Sum=753

Publishing Process of This Article

Item

Count

Browse

261

Download

686

Sum=947

Oct 21, 2022 (publication date) through Nov 26, 2024

Times Cited of This Article

Times Cited (3)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Gastroenterol. Oct 21, 2022; 28(39): 5750-5763
Published online Oct 21, 2022. doi: 10.3748/wjg.v28.i39.5750

Open in New Tab Full Size Figure Download Figure

Figure 1 Overall survival at 12 mo in patients with and without immune checkpoint inhibitor-mediated colitis. Kaplan-Meier curve of overall survival at 12 mo in patients with immune checkpoint inhibitor-mediated colitis (IMC, red) and without IMC (black). IMC: Immune checkpoint inhibitor-mediated colitis; HR: Hazard ratio.

Citation: Weingarden AR, Gubatan J, Singh S, Balabanis TC, Patel A, Sharma A, Habtezion A. Immune checkpoint inhibitor-mediated colitis is associated with cancer overall survival. World J Gastroenterol 2022; 28(39): 5750-5763
URL: https://www.wjgnet.com/1007-9327/full/v28/i39/5750.htm
DOI: https://dx.doi.org/10.3748/wjg.v28.i39.5750